SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
15077021
Source:
http://linkedlifedata.com/resource/pubmed/id/15077021
Search
Subject
(
60
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0038952
,
umls-concept:C0237798
,
umls-concept:C0388088
,
umls-concept:C0450127
,
umls-concept:C0556643
,
umls-concept:C0676831
,
umls-concept:C0919455
pubmed:issue
6
pubmed:dateCreated
2004-4-12
pubmed:abstractText
In a preclinical, nonhuman primate islet allotransplant model, the authors evaluated a novel immunosuppressive combination of basiliximab for induction and of RAD and FTY720 for maintenance.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0132144
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal
,
http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Propylene Glycols
,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Fusion Proteins
,
http://linkedlifedata.com/resource/pubmed/chemical/Sirolimus
,
http://linkedlifedata.com/resource/pubmed/chemical/Sphingosine
,
http://linkedlifedata.com/resource/pubmed/chemical/basiliximab
,
http://linkedlifedata.com/resource/pubmed/chemical/everolimus
,
http://linkedlifedata.com/resource/pubmed/chemical/fingolimod
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0041-1337
pubmed:author
pubmed-author:CottensSylvainS
,
pubmed-author:HeringBernhard JBJ
,
pubmed-author:KenyonNorma SNS
,
pubmed-author:KenyonNorman MNM
,
pubmed-author:KirchhofNicoleN
,
pubmed-author:LakePhilipP
,
pubmed-author:MullonClaudyC
,
pubmed-author:RicordiCamilloC
,
pubmed-author:WijkstromMartinM
pubmed:issnType
Print
pubmed:day
27
pubmed:volume
77
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
827-35
pubmed:dateRevised
2008-6-5
pubmed:meshHeading
pubmed-meshheading:15077021-Animals
,
pubmed-meshheading:15077021-Antibodies, Monoclonal
,
pubmed-meshheading:15077021-Diabetes Mellitus, Experimental
,
pubmed-meshheading:15077021-Graft Rejection
,
pubmed-meshheading:15077021-Graft Survival
,
pubmed-meshheading:15077021-Immunosuppressive Agents
,
pubmed-meshheading:15077021-Islets of Langerhans
,
pubmed-meshheading:15077021-Islets of Langerhans Transplantation
,
pubmed-meshheading:15077021-Macaca fascicularis
,
pubmed-meshheading:15077021-Propylene Glycols
,
pubmed-meshheading:15077021-Recombinant Fusion Proteins
,
pubmed-meshheading:15077021-Sirolimus
,
pubmed-meshheading:15077021-Sphingosine
pubmed:year
2004
pubmed:articleTitle
Islet allograft survival in nonhuman primates immunosuppressed with basiliximab, RAD, and FTY720.
pubmed:affiliation
Diabetes Institute for Immunology and Transplantation, Department of Surgery, University of Minnesota, Minneapolis, 55455, USA.
pubmed:publicationType
Journal Article
,
Research Support, Non-U.S. Gov't